The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 126.50
Bid: 125.00
Ask: 128.00
Change: 4.50 (3.69%)
Spread: 3.00 (2.40%)
Open: 122.00
High: 126.50
Low: 122.00
Prev. Close: 122.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares & TVR

20 Mar 2023 08:49

RNS Number : 5120T
Transense Technologies PLC
20 March 2023
 

The following announcement replaces the announcement issued today, 20 March 2023, at 07.00 under RNS number 4442T in its entirety, which was issued in error and duplicated the announcement issued on 13 March 2023 at 14.49 under RNS number 7923S. The full correct announcement is set out below.

 

Transense Technologies plc

("Transense" or the "Company")

 

Transaction in own shares

Change to Total Voting Rights

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that the Company has purchased 75,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price of 86.0 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 729,027. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 15,708,713 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.

 

 

Aggregate information:

Shares purchased:

Transense Technologies plc (ISIN CODE: GB00BDHDTH21)

Date of purchases:

17 March 2023

Investment firm

Shard Capital Stockbrokers

Venue

London Stock Exchange

Number of ordinary shares purchased

75,000

Volume-weighted average price, pence

86.0

Highest price paid (per ordinary share), pence

86.0

Lowest price paid (per ordinary share), pence

86.0

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, electric motors & drives, industrial machinery and performance automotive. 

The Company 's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com .

For further information please contact transense@walbrookpr.com

 

Schedule of Purchases - Individual Transactions

 

Number of Shares

Price Per Share (pence)

Trading Venue

Date of Transaction

Time of transaction

75,000

86.0

London Stock Exchange

17 March 2023

16:35:00

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSJMMPTMTITMBJ
Date   Source Headline
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company
11th Oct 200710:34 amRNSStatement re. Suspension
11th Oct 200710:30 amRNSSuspension - Transense Tech.
28th Sep 20077:03 amRNSInterim Results
25th Sep 20074:25 pmRNSHolding(s) in Company
9th Aug 200711:44 amRNSAIM Rule 26 Compliance
8th Aug 200712:11 pmRNSPatent Agreement
20th Jun 20073:45 pmRNSDirector/PDMR Shareholding
12th Jun 20073:39 pmRNSTotal Voting Rights
25th May 20073:10 pmRNSAGM Statement
24th May 200711:30 amRNSAGM Statement
10th May 20076:04 pmRNSDirector/PDMR Shareholding
19th Apr 20078:00 amRNSDirector/PDMR Shareholding
17th Apr 200710:29 amRNSDirector Resignation
11th Apr 200712:17 pmRNSDirector/PDMR Shareholding
10th Apr 20074:16 pmRNSHolding(s) in Company
30th Mar 20077:03 amRNSFinal Results
14th Mar 20073:49 pmRNSHolding(s) in Company
8th Mar 20072:59 pmRNSHolding(s) in Company
1st Mar 20075:32 pmRNSHolding(s) in Company
26th Feb 20074:14 pmRNSHolding(s) in Company
22nd Feb 20072:20 pmRNSHolding(s) in Company
22nd Feb 20072:15 pmRNSHolding(s) in Company
14th Feb 20074:05 pmRNSHolding(s) in Company
15th Jan 20075:51 pmRNSHolding(s) in Company
10th Jan 20071:45 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSRe Agreement
27th Nov 20067:01 amRNSRe Agreement
13th Nov 200612:18 pmRNSHolding(s) in Company
8th Nov 20063:35 pmRNSHolding(s) in Company
3rd Nov 20067:00 amRNSMichelin launches TPMS
1st Nov 20065:31 pmRNSHolding(s) in Company
31st Oct 20064:23 pmRNSHolding(s) in Company
30th Oct 20069:40 amRNSStatement re Press Comment
19th Oct 20064:19 pmRNSHolding(s) in Company
22nd Sep 20067:01 amRNSInterim Results
22nd Sep 20067:01 amRNSAgreement with Lear Corp.
22nd Sep 20067:01 amRNSHolding(s) in Company
18th Sep 200612:02 pmRNSHolding(s) in Company
15th Sep 20062:23 pmRNSHolding(s) in Company
7th Jul 20064:44 pmRNSHolding(s) in Company
6th Jul 20067:01 amRNSRe Agreement
13th Jun 200612:24 pmRNSHolding(s) in Company
13th Jun 200612:23 pmRNSHolding(s) in Company
19th May 20067:01 amRNSAGM Statement
21st Apr 20064:49 pmRNSHolding(s) in Company
10th Apr 200611:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.